Invited Review: Cell Damage in Inflammatory and Infectious Sites Might Involve A Coordinated “Cross-Talk” Among Oxidants, Microbial Haemolysins and Ampiphiles, Cationic Proteins, Phospholipases, Fatty Acids, Proteinases and Cytokines (An Overview)

References

• Bemheimer A. W., Rudy B. Interaction between membranes and cytolytic peptides. Biochemica Biophvsica Ada 1986; 864: 123–141
   PubMedGoogle Scholar
• Scotland S. M. Toxins. Journal of Applied Bacteriology 1988; 109S–1295, Suppl
   Google Scholar
• Bayson K. F., Cohen J. Bacterial endotoxins and current concept in diagnosis and treatment of endotoxemia. Journal of Medical Microbiology 1990; 31: 73–78
   PubMedGoogle Scholar
• Diran J. E. Biological effects of endotoxins. In: Gut-derived infectious toxic shock (GITS). Current Studies in Hematology and Blood Transfusion, H. Cottier, R. Kraft. Karger, Basel 1992; 59: 66–99
   Google Scholar
• Rietchel E. T., Kirika E. T.S., Schahde U., Mamat U., Schmidt G., Loppnow H., Ulmer A. J., Zahringer U., Seydel U., Di Padova F., Schreier M., Brade H. Bacterial endotoxin: molecular relationship of structure to activity and function. FASEB Journal 1994; 8: 217–225
   PubMedGoogle Scholar
• Bacterial enzymes and virulence, I. Holder. CRC Press, Boca Raton, Florida 1985
   Google Scholar
• Ginsburg I. Streptococcal enzymes and virulence. Bacterial enzymes and virulence, I. Holder. CRC Press, Boca Raton, Florida 1985; 121–144
   Google Scholar
• Giborowski P., Jeljazewicz J. Staphylococcal enzymes and virulence. Bacterial enzymes and virulence, I. Holder. CRC Press, Boca Raton, Florida 1985; 146–183
   Google Scholar
• Hentges D. J., Smith L. D.S. Hydrolytic enzymes as virulence factors of anaerobic bacteria. Bacterial enzymes and virulence, I. Holder. CRC Press, Boca Raton, Florida 1985; 105–119
   Google Scholar
• Ginsburg I., Sela M. N. The role of leukocytes and their hydrolases in the persistence, degradation and transport of bacterial constituents in tissues, relation to chronic inflammatory processes in staphylococcal, streptococcal and mycobacterial infections and in chronic periodontal disease. Critical Reviews in Microbiology 1976; 4: 249–332
   Google Scholar
• Ginsburg I. The role of lysosomal factors of leukocytes in the biodegradation and storage of microbial constituents in infectious granulomas. Lysosomes in applied biology and therapeutics, J. T. Dingle, P. J. Jacques, I. H. Shaw. North Holland Publication, Amsterdam 1972; Vol. 6: 327–406
   Google Scholar
• Schrinner E., Richmond M. H., Seibert G., Schwarz U. Surface structures of microorganisms and their interactions with the mammalian host. VCH Publishers, WeinheimFederal Republic of Germany 1988
   Google Scholar
• Halliwell B., Gutteridge J. M.C. Free radicals in biology and medicine. 2nd edition. Clarenton Press, Oxford 1989
   Google Scholar
• Gallin J. I., Goldstein M., Snyderman R. Inflammation, basic principles and clinical correlates. Raven Press, New York 1992
   Google Scholar
• Klebanoff S. F. Oxygen metabolites from phagocytes. Inflammation, basic principles and clinical correlates, 2nd edition, J. I.L. Gallin, M. Goldstein, R. Snyderman. Raven Press, New York 1992; 541–588
   Google Scholar
• Farber J. L., Kyle M. E., Coleman J. B. Mechanisms of cell injury by active oxygen species. Laboratory Investigation. 1990; 62: 670–679
   PubMed Web of Science ®Google Scholar
• Ward P. A., Varani J. Mechanisms of neutrophil-mediated killing of endothelial cells. Journal of Leukocyte Biology 1990; 48: 97–102
   PubMed Web of Science ®Google Scholar
• Dean R. T., Gieseg S., Davies M. J. Reactive species and their accumulation on radical-damaged proteins. Trends in Biological sciences 18 November, 1993; 437–441
   PubMedGoogle Scholar
• Henson P. M., Johnston R. B. Tissue injury in inflammation, oxidants, proteinases and cationic proteins. Journal of Clinical Investigation 1987; 79: 669–674
   PubMed Web of Science ®Google Scholar
• Ginsburg I. Cationic polyelectrolytes, a new look at their possible roles as opsonins, as stimulators of the respiratory burst in leukocytes, in bacteriolysis and as modulators of immune complex disease. Inflammation 1987; 11: 489–515
   PubMed Web of Science ®Google Scholar
• Hammann K. J., Barker R. L., Ten R. M., Gleich G. J. The molecular biology of eosinophil granule proteins. International Archives of Allergy and Applied Immunology 1991; 94: 202–209
   PubMedGoogle Scholar
• Spitznagel J. K. Antibiotic proteins of human neutrophils. Journal of Clinical Investigation 1990; 86: 1386–1391
   Google Scholar
• Elsbach P., Weiss J. Phagocytic cells; oxygen independent antimicrobial system. Inflammation basic principles and clinical correlates, 2nd ed., J. I. Gallin, I. M. Goldstein, R. Snyderman. Raven Press, New York 1992; 445–470
   Google Scholar
• Leherer R. I. Defensins, antimicrobial and cytotoxic peptides of mammalian cells. Annual Review of Immunology 1993; 11: 105–128
   PubMedGoogle Scholar
• Mizel S. B. The interleukins. FASEB Journal. 1989; 3: 2379–2388
   PubMed Web of Science ®Google Scholar
• Cerami A. Inflammatory cytokines. Clinical Immunology unit Immunopathology. 1992; 62: 53–510
   Google Scholar
• Collen D., Lijnen H. R. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood. 1991; 78: 3114–3124
   PubMed Web of Science ®Google Scholar
• Morgan B. B. Complement membrane attack on nucleated cells, resistance, recovery and non-lethal effects. Biochemical Journal 1989; 264: 1–15
   PubMed Web of Science ®Google Scholar
• Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB Journal. 1992; 6: 3051–306
   PubMed Web of Science ®Google Scholar
• Koltai M., Hosford D., Braquet P. Role of PAF and cytokines in microvascular tissue injury. Journal of Laboratory and Clinical Medicine. 1992; 119: 461–466
   PubMedGoogle Scholar
• Cytotoxic T-cells. biology and relevance to disease. Annuls of the New York Academy of Sciences. 1988; 532
   Google Scholar
• McCord J. M. Free radicals in myocardial ischemia, overview and outlook. Free Radicals in Biology and Medicine. 1988; 4: 914–26
   Google Scholar
• The respiratory burst and its physiological significance, A. J. Sbarra, R. R. Strauss. Plenum Press, New York 1988
   Google Scholar
• Groot G. D., Littauer A. Hypoxia, reactive oxygen and cell injury. Free Radicals in Biology and Medicine. 1989; 6: 541–551
   PubMed Web of Science ®Google Scholar
• Halliwell B. Free radicals, reactive oxygen species and human disease, a critical evaluation with special reference to atherosclerosis. British Journal of Experimental Pathology. 1989; 70: 737–757
   PubMed Web of Science ®Google Scholar
• Halliwell B., Chirico S., Kaur H., Aruoma O. I., Grootveld M., Blake D. R. Oxidative Damage and Repair Chemical and Medical Aspects, K. J.A. Davies. Pergamon Press, New York 1993; 846–853
   Google Scholar
• Kontos A. Oxygen radicals in CNS damage. Cliemico-Biologicul Interactions. 1989; 72: 229–255
   PubMed Web of Science ®Google Scholar
• Slivka A., LoBuglio A. F., Weiss S. J. A potential role for hypochlorous acid in granulocyte mediated tumor-cell toxicity. Blood. 1989; 55: 3477–3500
   Google Scholar
• Weiss S. J. Tissue destruction by neutrophils. New England Journal of Medicine. 1989; 320: 365–376
   PubMed Web of Science ®Google Scholar
• Jestis A. J., Ginn M. T., Mukhergee G. P., Ward A., Dratz E. A. Death by oxygen, radical views. The New Biologist. 1991; 3: 651–655
   PubMedGoogle Scholar
• Seifert R., Schultz G. The superoxide-forming NADP, H oxidase of phagocytes. An enzyme system regulated by multiple mechanisms. Review of Physiology Biochemistry and Pharmacology. 1991; 117: 1–510
   PubMed Web of Science ®Google Scholar
• Morel F., Doussers J., Vignais P. V. The superoxide-generating oxidase of phagocytic cells. Physiology, molecular and pathological aspects. European Journal of Biochemistry. 1991; 201: 523–546
   PubMedGoogle Scholar
• Van Der Vilt A., Bast A. Role of reactive oxygen species in intestinal diseases. Free Radicals in Biology and Medicine. 1991; 12: 499–513
   Google Scholar
• Nordmann R., Ribier C., Rouach H. Implication of free radical mechanisms in cthanol-induced cellular injury. Free Radicals in Biology and Medicine. 1992; 12: 219–240
   PubMed Web of Science ®Google Scholar
• Baggiolini M., Boulay F., Badwey J. A., Curnutte J. T. Activation of neutrophil leukocytes. chemoattractant receptor and respiratory burst. FASEB Journal 1993; 7: 1004–1010
   PubMed Web of Science ®Google Scholar
• Jansen Y. M.W., Van Houten B., Brom P. A.J., Mossman B. T. Cell and tissue responses to oxidative damage. Laboratory Investigation. 1993; 69: 261–274
   PubMedGoogle Scholar
• Lehr H. A., Arfors K. E. Mechanisms of tissue damage by leukocytes. Current Opinion in Hematology. 1994; 1: 92–99
   PubMedGoogle Scholar
• McPhail L. C., Henson P., Johnston R. B. Respiratory burst enzyme in human neutrophils, evidence for multiple mechanisms of activation. Journal of Clinical Investigation 1981; 67: 710–716
   PubMedGoogle Scholar
• Ginsburg I., Borinski R., Lahav M., Matzner Y., Elliasson I., Christensen P., Malamud D. Poly-L-arginine and N-formulated chemotactic peptide act synergistically with lectins and calcium ionophore to induce intense chemiluminescence and superoxide production by human blood leukocytes. Inflammation. 1985; 8: 1–26
   Google Scholar
• Ginsburg I. I. Mechanisms of cell and tissue injury induced by group A streptococci: relation to poststreptococcal sequelae. Journal of Infectious Diseases 1972; 126: 294, 340, 419–456
   PubMed Web of Science ®Google Scholar
• Ginsburg I. Action of streptococcal hemolysins and proteolytic enzymes on Enrlich ascites tumor cells. British Journal of Experimental Pathology 1959; 40: 417–423
   PubMedGoogle Scholar
• Ginsburg I., Ram N. Effect of antibodies and plasmin on Enrlich ascites tumor cells. Nature 1963; 185: 328–330
   Google Scholar
• Schraufstatter I. V., Browner K., Harris A., Hyslop P. A., Jackson J. H., Quehenberger O., Cochrane C. G. Mechanisms of hypochlorite injury to targets. Journal of Clinical Investigation 1990; 85: 554–562
   PubMed Web of Science ®Google Scholar
• Brenofsky C. Nucleotide chloramines and neutrophil-mediated cytotoxicity. FASEB Journal 1991; 5: 295–300
   PubMedGoogle Scholar
• Schraufstatter I. V., Hyslop P. A., Jackson J., Cochrane C. C. Mechanisms of oxidant injury of cells. Leukocyte migration unci its sequellae, M. Moval, 1986; 1150–1160, Satellite symposium of the 6th international congress on immunology
   Google Scholar
• Liechtenstein A. Mechanisms of neulrophil-mediated oxidative and non-oxidalive tumor lysis. New Horizons of Tumor Immunotherapy, M. Torisu, Y. Yoshida. Elsvier Science Publisher B. V. (Biomedical Division). 1989; 79–100
   Google Scholar
• Orrenius S. Mechanisms of oxidative cell damage. Free radicals from basic science to medicine, G. Poli, Fi. Albano, M. U. Dianzani. Birkhauser Verlag, BaselSwitzerland 1990; 47–64
   Google Scholar
• Ward P. A. Mechanisms of endothelial cell injury. Journal of Laboratory and Clinical Medicine. 1991; 118: 421–426
   PubMedGoogle Scholar
• Vlessis A. A., Muller O., Bartos D., Trunkey D. Mechanisms of peroxide-induced cellular injury in cultures and adult myocytes. FASEB Journal. 1991; 5: 2600–2605
   PubMedGoogle Scholar
• Hallecki M. M., Richburgand J. H., Kaufman F. C. Reversible and irreversible oxidant injury to PC12cellsby hydrogen peroxide. Free Radicals in Biology and Medicine. 1992; 12: 137–144
   PubMedGoogle Scholar
• Janssen Y. M.W., Van Houten B., Borm P. J.A., Mossman B. T. Cell and tissue responses to oxidative damage. Laboratory Investigation. 1993; 69: 261–274
   PubMed Web of Science ®Google Scholar
• Baker M. S., Feigan J., Lowlher D. A. The mechanism of chondrocyte hydrogen peroxide damage. Depletion of intracellular ATP due to suppression of glucolysis caused by oxidation of glyceraldehydc-3-phosphate dehydrogenase. Journal of Rheumatology. 1989; 16: 7–14
   PubMed Web of Science ®Google Scholar
• Varani J., Phan S. E., Gibbs D. I., Ryan U. S., Ward P. A.P.A. H2O2-mediated cytotoxicity of rat pulmonary endothelial cells, changes in adenosine triphosphate and purine products and effects of protective interventions. Laboratory Investigation. 1990; 63: 683–689
   PubMed Web of Science ®Google Scholar
• Sprag R. G. DNA strand break formation following exposure of bovine pulmonary artery and aortic endothelial cells to reactive oxygen products. American Journal of Respiratory and Cell Biology 1991; 4: 4–10
   PubMedGoogle Scholar
• Alto T. K., Raivio K. O. Mechanisms of adenine nucleotide depletion from endothelial cells exposed to reactive oxygen metabolites. Free Radicals in Biology and Medicine. 1993; 14: 177–183
   PubMedGoogle Scholar
• Mehrotra S., Makkar P., Wiswanathan P. M. Mitochondrial damage by oxygen species in vitro. Free Radicals in Biology and Medicine. 1991; 10: 277–283
   PubMed Web of Science ®Google Scholar
• Yamamoto Y., Niki E., Eguchi J., Shimasaki H. Oxidation of biological membranes and its inhibition. Free radical chain oxidation of erythrocyte ghost membrane by oxygen. Biochemica et Biophysica Ada. 1985; 819: 29–36
   PubMed Web of Science ®Google Scholar
• Vercelotti G. M., Severson S. P., Duane P., Moldow C. F. Hydrogen peroxide alters signal transduction in human endothelial cells. Journal of Laboratory and Clinical Medicine. 1991; 117: 15–24
   PubMed Web of Science ®Google Scholar
• Bradley J. R., Johnson D. R., Pober J. S. Endothelial cells activation by hydrogen peroxide. Selective increases of intracellular adhesion molecule-1 and major histocompatibility complex class 1. American Journal of Pathology. 1993; 142: 1598–1609
   PubMed Web of Science ®Google Scholar
• Winn J. S., Guille J., Gebieki J. M., Day R. O. Hydrogen peroxide modulate respiratory burst in human neutrophils. Biochemical Pharmacology 1990; 41: 31–36
   Google Scholar
• Shingu M., Nonaka S., Nisimukai H., Nobunaga M., Kitamura H., Tomooka K. Activation of complement in normal serum by hydrogen peroxide and hydrogen peroxide-related oxygen radicals produced by activated neutrophils. Immunology 1992; 90: 72–78
   Google Scholar
• Vogt V., Damerau B., Von Zabern I., Nolteand R., Brunahl D. Non-enzymatic activation of the fifth component of human complement, by oxygen radicals. Some properties of the activation product C5b-like C5. Molecular Immunology 1989; 26: 1133–1142
   PubMedGoogle Scholar
• Natarajan W., Taher M. M., Roehm B., Parinadi N. L., Schmidt H. H.O., Kiss Z., Garcia J. G.N. Activation of endothelial cells phospholipase D by hydrogen peroxide and fatty acid hydroperoxide. Journal of Biological Chemistry 1993; 268: 930–937
   PubMed Web of Science ®Google Scholar
• Ginsburg I., Harris T. N. Oxygen-stable hemolysins of group A streptococci. IV. The mechanisms of lysis of red blood cells by the cell-bound hemolysin. Journal of Experimental Medicine 1965; 121: 647–653
   PubMedGoogle Scholar
• Marcus Z., Davies M., Ginsburg I. Oxygen-stable hemolysins of group A streptococci. V. Effect on rat heart and kidney cells grown in tissue culture. Experimental and Molecular Pathology. 1966; 5: 93–107
   PubMedGoogle Scholar
• Ginsburg I., Varani J. Interaction of viable group A streptococci and hydrogen peroxide in killing of vascular endothelial cells. Free Radicals in Biology and Medicine. 1993; 14: 495–500
   PubMed Web of Science ®Google Scholar
• Ginsburg I., Gibbs D. F., Schuger L., Johnson K. L., Ryan U. S., Ward P. A., Varani J. Vascular endothelial cells killing by combinations of membrane-active agents and hydrogen peroxide. Free Radicals in Biology and Medicine 1989; 7: 369–375
   PubMed Web of Science ®Google Scholar
• Ginsburg I., Misgav R., Pinson A., Varani J., Kohen R. Synergism among oxidants, proteinases, phospholipases, microbial hemolysins, cationic proteins, proteinases and cytokines. Inflammation 1992; 16: 519–538
   PubMed Web of Science ®Google Scholar
• Ginsburg I., Mitia R. S., Jr., Gibbs D. F., Varani J., Kohen R. Killing of endothelial cells and release of arachidonic acid, synergistic effects among hydrogen peroxide, membrane-damaging agents cationic substances and proteinases and their modulation by inhibitors. Inflammation. 1993; 17: 295–319
   PubMed Web of Science ®Google Scholar
• Elias N., Heller M., Ginsburg I. Binding of streptolysin Sto red blood cell ghosts and ghost lipids. Israel Journal of Medical Sciences. 1966; 2: 302–309
   PubMedGoogle Scholar
• Ginsburg I., Kohen R. Synergistic effects among oxidants, membrane-damaging agents, fatty acids, proteinases and xenobiotics: Killing of epithelial cells and the release of arachidonic acid. Inflammation. 1994; 19: 101–118, in press
   Google Scholar
• Davies K. J.A., Lin S. W., Pacific R. E. Protein damage and degradation by oxygen radicals. IV. Degradation of denatured proteins. Journal of Biological Chemistry 1987; 262: 9914–9920
   PubMed Web of Science ®Google Scholar
• Neuzil J., Gebicki J. M., Stocker R. Radical-induced chain oxidation of proteins and its inhibition by chain-breaking antioxidants. Biochemical Journal. 1993; 293: 601–606
   PubMed Web of Science ®Google Scholar
• Stadtman E. R. Protein oxidation and aging. Science 1992; 257: 1220–1224
   PubMed Web of Science ®Google Scholar
• Varani J., Ginsburg I., Gibbs D. F., Mukhopadhyay P. S., Sulavik C., Johnson K. J., Weinberg Y. M., Ryan U. S., Ward P. A. Hydrogen peroxide induced cell and tissue injury, protective effect of Mn2. Inflammation 1991; 15: 291–301
   PubMedGoogle Scholar
• Yedgar S., Dagan A., Dan P., Ginsburg I. Regulation of cell membrane phospholipase A: activity by cell-inpermeable inhibitors. Abstract In 3rd International Conference on Lipid Mediators in Health and Disease, Jerusalem, October 31, 1993; 25
   Google Scholar
• Raya S. A., Trembovler V., Shohami E., Lazarovici P. Cytolsins increase intracellular calcium and induce eicodanoids released by pheochromocytoma PC 12 cell culture. Natural Toxins 1993; 1: 263–270
   PubMedGoogle Scholar
• Grimminger G. F., Sibelius U., Bhakdi S., Sultropand N., Seeger W. Excherichia coli hemolysin is a potent inductor of phosphoinositide hydrogen and related metabolic responses in human neutrophils. Journal of Clinical Investigation 1991; 88: 1531–1539
   PubMedGoogle Scholar
• Sporn P. S., Peter-Golden M., Simon R. H. Hydrogen peroxide-induced arachidonic acid metabolism in the rat alveolar macrophages. American Journal of Respiratory Diseases. 1988; 137: 490–496
   Google Scholar
• Prasad M. R., Das D. K. Effect of oxygen-derived free radicals and oxidants on the degradation of in vitro of membrane phospholipids. Free Radicals Research Communications 1989; 7: 381–388
   PubMed Web of Science ®Google Scholar
• Murty S. N.S., Cooney C. G., Clearfield H. R. Hydrogen peroxide-induced alteration in prostaglandin secretion in rat colon in vitro. Inflammation 1990; 14: 645–661
   PubMedGoogle Scholar
• Duane P. G., Rice K. L., Charboneau D. E., King M. B., Gillboe D. P., Niewoehner D. E. Relationship of oxidant-mediated cytotoxicity to phospholipid metabolism in endothelial cells. American Journal of Respiratory and Molecular Biology 1991; 4: 408–416
   PubMed Web of Science ®Google Scholar
• Wickenand A. J., Knox K. W. Lipoteicholic acids, a new class of bacterial antigens. Science 1975; 187: 1161–1167
   PubMedGoogle Scholar
• Doran J. E. Biological effects of endotoxins in gut-derived infectious-toxic shock (GITS). Current Studies in Blood Transfusions, H. Cottier, R. Kraft. Karger, Basel 1992; 66–99, No. 59
   Google Scholar
• Raetz C. R.H., Ulevitch R. J., Wright S. D., Sibley C. H., Ding A., Nathan C. F. Gram-negative endotoxin: an extraordinary lipid with profound effect on eukaryotic signal transduction. FASEB Journal 1991; 5: 2652–2660
   PubMed Web of Science ®Google Scholar
• Neemanand N., Ginsburg I. Red cell sensitizing agent of group A streptococci. II. Immunological and immunopathological properties. Israel Journal of Medical Sciences 1971; 8: 1807–1816
   Google Scholar
• Ofek I., Beachey E. H., Jefferson W., Campbell G. L. Gel 1 Membrane binding properties of group A streptococcal lipoteichoic acid. Journal of Experimental Medicine 1975; 141: 990–1003
   PubMed Web of Science ®Google Scholar
• Lopathin D., Kessler R. E. Pretreatment with lipoteichoic acid sensitizes target cells to antibody-dependent cellular cytotoxicity in the presence of antilipoteichoic acid antibodies. Infection and Immunity 1985; 48: 638–643
   PubMedGoogle Scholar
• Winkelstein J. H., Thomasz A. Activation of the alternative complement pathway for pneumococcal cell-wall teichoic acid. Journal of Immunology 1978; 120: 174–178
   PubMed Web of Science ®Google Scholar
• Dishon T., Finkel R., Marcus Z., Ginsburg I. Cell sensitizing products of streptococci. Immunology 1967; 13: 555–564
   PubMed Web of Science ®Google Scholar
• Tobias P. S., Mathison J. C., Ulevitch R. J. A family of lipolysaccharide binding proteins involved in responses to Gram negative sepsis. Journal of Biological Chemistry 1988; 263: 13479–13481
   PubMed Web of Science ®Google Scholar
• Yamamoto A., Usami H., Nagamuta M., Sugawara Y., Hamada S., Yamamoto T., Kokeguchi S., Kotani S. The use of lipoteichoic acid (LTA) from streptococcus pyogenes to induce serum factor causing tumor necrosis. British Journal of Cancer 1985; 51: 737–742
   PubMedGoogle Scholar
• Ginsburg I., Fligeil S. E.G.P., Ward A., Varani J. Lipoteichoic acid-antilipoteichoic acid complexes induce superoxide generation by human neutrophils. Inflammation 1989; 12: 525–545
   Google Scholar
• Levi R., Kotob M., Nagauker O., Majmudar G., Alkan M., Ofek I., Beachey E. H. Stimulation of oxidative burst in human monocytes by lipoteichoic acid. Infection Immunity 1990; 58: 566–568
   PubMedGoogle Scholar
• Tarsky-Tsuk D., Levy R. Stimulation of the respiratory burst in peripheral blood monocytes by lipoteichoic acid. The involvement of calcium ions and phospholipase A:. Journal of Immunology. 1990; 144: 2665–2670
   PubMedGoogle Scholar
• Oshima Y., Beuth J., Yassin H., Ko H. L., Pulverer G. Stimulation of human monocyte chemiluminescence by staphylococcal lipoteichoic acid. Medical Microbiology and Immunology. 1988; 177: 115–121
   PubMedGoogle Scholar
• Keller R., Fischer W., Bassett S. Macrophage response to bacteria, induction of marked secretory and cellular activities by lipoteichoic acid. Infection and Immunity 1992; 60: 3364–3672
   Google Scholar
• Yagawa K., Kahku M., Ichinose Y., Nagao S., Tanaka A., Tomoda A. Bophasic effects of muramyl dipeptide and lipopolysaccharide on superoxide anion-generating activities of macrophages. Infection and Immunity. 1984; 45: 82–86
   PubMedGoogle Scholar
• Worthen G. S., Seccombe J. F., Clay K. L., Guthrie L. A., Johnston R. B. The priming of neutrophils by lipopolysaccharide for production of intracellular platelet-activating factor. Potential role in mediation of enhanced superoxide secretion. Journal of Immunology 1988; 140: 3553–3559
   PubMed Web of Science ®Google Scholar
• Wright G. G., Read P. W., Mandell G. L. Lipopolysaccharide release a priming substance for platelets that augment the oxidative response of polymorphonuclear neutrophils to chemolactic peptide. Journal Infectious Diseases 1988; 157: 690–696
   PubMed Web of Science ®Google Scholar
• Forehand J. R., Papst M. J., Phillips W. A., Johnston R. B. Lipopolysaccharide priming of human neutrophils for an enhanced respiratory burst, role of intracellular calcium. Journal of Clinical Investigation. 1989; 83: 74–83
   PubMed Web of Science ®Google Scholar
• Forehand J. R., Bomalski J. S., Johnston R. B. Mechanisms of lipopolysaccharide priming for enhanced respiratory burst in human neutrophils. New aspects of human polymorphonuclear leukocytes, W. H. Hirll, P. J. Schollmeyer. Plenum Press. 1991; 65–73
   Google Scholar
• Klein J. B., Payene V., Schcpers T. M., McLcish K. R. Bacterial lipopolysaccharide enhance polymorphonuclear leukocyte function independent of changes in intracellular calcium. Inflammation 1990; 14: 599–611
   PubMedGoogle Scholar
• Feme M., Duchan Z., Rabinovitz S., Seka M. N., Ginsburg I. The effect of leukocyte hydrolases on bacteria XII. The release of LPS from Salmonella typhi by leukocyte extracts, lysozyme, inflammatory exudates and by serum and synovial fluids and the modulation by anionic and cationic polyelectrolytes of LPS release and the sensitization of erythrocytes. Inflammation. 1978; 3: 59–80
   PubMedGoogle Scholar
• Sela M. N., Lahavand M., Ginsburg I. Effect of leukocyte hydrolases on bacteria IX. The release of lipoteichoic acid from group A streptococci and from Streptococcus mutatis by leukocyte extracts and by lysozyme, relation to tissue damage in inflammatory sites. Inflammation. 1977; 2: 151–164
   PubMedGoogle Scholar
• Horn D., Tomasz A. Release of lipoteichoic acid from Streptococcus sanguis. Stimulation of release during penicillin treatment. Journal of Bacteriology. 1979; 137: 1180–1184
   PubMedGoogle Scholar
• Nealon M. J., Beachey E. H., Courtney H. S., Simpson A. Release of fibronectin-lipoteichoic acid complexes from group A streptococci with penicillin. Infection and Immunity 1986; 51: 529–533
   PubMedGoogle Scholar
• Sela M., Katchalski E. Biological properties of poly alpha amino acids. Advances in Protein Chemistry 1959; 14: 391–478
   PubMedGoogle Scholar
• The pathogenicity of cationic proteins, P. P. Lambert, P. Bergmann, R. Beauwens. Raven Press, New York 1983
   Google Scholar
• Ackerman S. J., Loegering D. A., Venge P., Olsson I., Harley J. B., Fauci A. S., Gleich G. J. Distinctive cationic proteins of the human eosinophil granule: major basic protein, osinophilic cationic protein and eosinophil-derived neurotoxin. Journal of Immunology 1983; 131: 2982–29997
   Google Scholar
• Lehrer R. I., Ganz T., Selsted M. E., Babior B. M., Cumutte J. T. Neutrophils and host defense. Annals of Internal Medicine 1988; 109: 127–142
   PubMed Web of Science ®Google Scholar
• Gleich G. J., Ottesen E. A., Leiferman K. M., Ackerman S. J. Eosinophils and human disease. International Archives of Allergy and Applied Immunology 1989; 88: 59–62
   PubMedGoogle Scholar
• Gleich G. J. Eosinophilic granule basic proteins. Clinical Immunology News 1990; 10: 15–18
   Google Scholar
• Spitznagel J. K. Antibiotic proteins of human neutrophils. Journal of Clinical Investigation. 1990; 86: 1381–1386
   PubMedGoogle Scholar
• Kagen B. L., Ganz T., Lehrer R. I. Defensins: a family of antimicrobial and cytotoxic peptides. Toxicology 1994; 87: 131–149
   PubMedGoogle Scholar
• Gabay J. E., Almeida R. P. Antobiotic peptide and serine protease homologs in human polymorphonuclear leukocytes, defensins and azurocidin. Current Opinion in Immunology 1993; 5: 97–102
   PubMed Web of Science ®Google Scholar
• Lichtenstein A. K., Ganz T., Selsted M. E., Lehrer R. I. In vitro tumor cells cytolysis by peptide defensins of human and rabbit granulocytes. Blood 1986; 68: 1407–1410
   PubMed Web of Science ®Google Scholar
• Morgan D. M.L., Clover J., Pearson J. D. Effects of synthetic polycations on leucine incorporation, lactate dehydrogenase release and morphology of human umbilical vein endothelial cells. Journal of Cell Science. 1988; 91: 231–238
   PubMed Web of Science ®Google Scholar
• Van Kent P. E.M., Dekker C., Mosterd L., Van Den Bersselaar L., Van Den Berg W. B. Allergic arthritis induced by calionic proteins, role of molecular weight. Immunology 1989; 67: 447–452
   PubMedGoogle Scholar
• Okrent D. G., Lichtenstein A. K., Ganz T. Direct cytotoxicity of polymorphonuclear leukocyte granule protein to human lung-derived cells and endothelial cells. American Review of Respiratory Disease. 1990; 141: 179–185
   PubMed Web of Science ®Google Scholar
• Batsford S. R. Cationic antigens as mediators of inflammation. Acta Pathologica Microbiologica et Immunologica Scandinavia 1991; 99: 1–9
   PubMedGoogle Scholar
• Ginsburg I., Sela M. N., Morag A., Ravid Z., Duchan Z., Feme M., Rabinevitz-Bergner S., Page-Thomas P., Davies P., Nichols J., Humes J., Bonney R. The role of leukocyte factors and cationic polyelectrolytes in the phagocytosis of group A streptococci and Candida albicans by neutrophils macrophages, fibroblasts and epithelial cells, modulation by anionic polyelectrolytes in relation to the pathogenesis of chronic inflammation. Inflammation. 1981; 5: 289–312
   PubMedGoogle Scholar
• Ginsburg I., Fligeil S. E.G., Kunkell R. G., Riser B. L., Varani J. Phagocytosis of Candida albicans enhances malignant behavior of murine tumor cells. Science 1987; 238: 1573–1575
   PubMed Web of Science ®Google Scholar
• Ginsburg I., Borinski R., Sadovnic M., Elkam Y., Raisford K. Poly-L-histidine, a potent stimulator of superoxide generation in human blood leukocytes. Inflammation 1987; 11: 253–277
   PubMedGoogle Scholar
• Ginsburg I., Borinski R., Malamud D., Struckmayer F., Klimetzek V. Chemiluminescence and superoxide generation by leukocytes stimulated by polyelectrolytes opsonized bacteria, role of polyarginine, polylysine, polyhistidine cytochalasins and inflammatory exudates as modulators of the oxygen burst. Inflammation 1985; 9: 245–271
   PubMedGoogle Scholar
• Ginsburg I. Cationic polyelectrolytes, potent opsonic agents which activate the respiratory burst in leukocytes. Free Radical and Research Communications 1989; 8: 11–26
   PubMed Web of Science ®Google Scholar
• Moy J. N., Gleich G. J., Thomas L. L. Noncytotoxic activation of neutrophils by eosinophil granule major basic protein: effect on superoxide anion generation and lysosomal enzyme release. Journal of Immunology 1990; 145: 2626–2632
   PubMed Web of Science ®Google Scholar
• Oseas R. S., Allen J., Yang H. H., Baehner R. L., Boxer L. A. (Rabbit cationic protein enhances leukocyte adhesiveness. Immunology 1981; 33: 523–526
   Google Scholar
• Warren J. S.P., Ward A., Johnson K. J., Ginsburg I. Modulation of acute immune-complex-mediated tissue injury by the presence of polyanionic substances. American Journal of Pathology 1987; 128: 67–77
   PubMedGoogle Scholar
• Geffner J. R., Trevani A. S., Schatner M., Malchiodi E., Lopez D. H., Lazzari M., Isturiz M. A.M.A. Activation of human neutrophils and monocytes induced by immune complexes prepared with cationized antibodies and antigens. Clinical Immunology and Immunopathology 1993; 69: 9–15
   PubMedGoogle Scholar
• Weiler J. M., Edens R. R., Gleich G. J. Eosinophil granule cationic poteins regulate complement. I. Activity on the alternative pathway. Journal of Immunology 1992; 149: 643–648
   PubMed Web of Science ®Google Scholar
• Meedham L., Hallewell P. G., Williams T. J., Gordon J. L. Endothelial function responses and increased vascular permeability induced by polycations. Laboratory Investigations. 1989; 59: 538–548
   Google Scholar
• Thomas L. L., Zheutilin L. M., Gleich G. J. Pharmacological control of human basophil histamine release stimulated by eosinophil granule major basic proteins. Immunology. 1989; 66: 611–615
   PubMedGoogle Scholar
• Shapiro D. N., Varani J., Ginsburg I. Activation of murine cell hybridoma by cationized bacteria. Immunology 1989; 67: 478–483
   PubMed Web of Science ®Google Scholar
• Ginsburg I. The biochemistry of bacteriolysis, paradoxes, facts and myths. Microbiological Sciences 1988; 5: 137–142
   PubMedGoogle Scholar
• Lichtenstein A. K., Ganz T., Nguyen T. M., Selsted M. E., Lehrer R. L. Mechanism of target cell cytolysis by peptide defensins, target cell metabolic activities, possibly involving endocytosis, are crucial for expression of cytotoxicity. Journal of Immunology 1988; 140: 2686–2696
   PubMed Web of Science ®Google Scholar
• Kagan B. L., Selsted M. E., Ganz T., Leprer R. I. Antimicrobial defensin peptide form voltage-dependent ion-permeable channels in planar bilayer membranes. Proceeding of the National Academy of Sciences of the United States of America 1990; 87: 210–214
   PubMed Web of Science ®Google Scholar
• Lichtenstein A. Mechanism of mammalian cell lysis mediated by peptide defensins. evidence for an initial alteration of the plasma membrane. Journal of Clinical Investigation. 1991; 88: 93–100
   PubMed Web of Science ®Google Scholar
• Barker R. L., Gindel R. H., Gleich G. J., Checkel J. L., Loegering D. A., Pease L. R., Hamann K. L. Acidic polyamino acids inhibit human eosinophil granules major basic protein toxicity, evidence of a functional role for ProMBP. Journal of Clinical Investigation 1993; 88: 798–805
   Google Scholar
• Lichtenstein A. K., Ganz T., Selsted M., Lehrer R. I. Synergistic cytolysis mediated by hydrogen peroxide combined with peptide defensins. Cellular Immunology 1988; 114: 104–116
   PubMed Web of Science ®Google Scholar
• Yazdanbakish M., Tai P. C., Spry C. J., Gleich G. J., Roos D. Synergism between eosinophil cationic protein and oxygen metabolites in killing of Schistosomula of Schistosoma mansoni. Journal of Immunology 1987; 138: 3443–3447
   PubMedGoogle Scholar
• Klebanoff S. J. Myeloperoxidase-halide-hydrogen peroxide antibacterial system. Journal of Bacteriology 1968; 95: 2131–2138
   PubMed Web of Science ®Google Scholar
• Klebanoff S. J., Waltersdorph A. M., Rosen H. An antimicrobial activity of myeloperoxidase. Methods in Enzymology 1984; 105: 399–403
   PubMed Web of Science ®Google Scholar
• Johnson R. J., Couscr W. G., Chi E. Y., Adler S., Klebanoff S. J. New mechanism for glomerular injury. Mycloperoxidase-hydrogen peroxide-halide system. Journal of Clinical Invesligation. 1987; 79: 1379–1387
   PubMed Web of Science ®Google Scholar
• Johnson R. J., Guggenheim S. J., Klebanoff S. J., Ochi R. F., Wass A., Baker P., Schulze M., Courser W. G. Morphological correlates of glomerular oxidant injury induced by the mycloperoxidase-hydrogen peroxide-halide system of the neutrophil. Laboratory Investigations. 1988; 5: 294–301
   Google Scholar
• Weiss S. J., Young J., Lobuglio A. F., Slivka A., Nimen N. F. Role of H2O2 in neutrophil-medialed destruction of cultured endothelial cells. Journal of Clinical Investigation. 1981; 68: 714–721
   PubMed Web of Science ®Google Scholar
• Ferrante A., Kowanko I. C., Bates E. J. Mechanisms of host tissue damage by cytokine-ac-tivated neutrophils. Linnumologv Series, R. G. Coffey, M. Dekker, 1992; Vol. 5: 499–521
   Google Scholar
• Agosti J. M., Altman L. C., Garrison H. A., Loegering D. A., Gleich G. J., Klebanoff S. J. The injurious effect of eosinophil peroxidase, hydrogen peroxide and halide on pneumocyles in vitro. Journal of Allergy and Clinical Immunology. 1987; 79: 496–504
   PubMed Web of Science ®Google Scholar
• Motojima S., Frigas E., Loegering D. A., Gleich G. J. (Toxicity of eosinophil cationic proteins for guinea pig tracheal eothelium in vitro. American Review of Respiratory Disease 1989; 139: 801–806
   PubMed Web of Science ®Google Scholar
• Ayars C. H., Altman L. C., McManus M. N., Agosti J. M., Baker C., Luchtel D. L., Loegering D. A., Gleich G. J. Injurious effect of the beosinophil peroxide-hydrogen peroxide-halide system and major basic protein on human nasal epithelium in vitro. American Review of Respiratory Disease. 1989; 140: 125–131
   PubMed Web of Science ®Google Scholar
• Klebanoff S. J., Agisti J. B., Jorgand A., Waltersdorph A. M. Comparative toxicity of the horse eosinophil peroxidase-H2O2-halide system and granule basic isoproteins. Journal of Immunology. 1989; 143: 239–244
   PubMedGoogle Scholar
• Slungaard A., Mahoney J. R. Bromide-dependent toxicity of eosinophil peroxidase for endothelium and isolated working rat hearts, a model for eosinophilic endocarditis. Journal of Experimental Medicine 1991; 173: 117–126
   PubMed Web of Science ®Google Scholar
• Sela M. N., Ofek I., Lahav M., Ginsburg I. The effect of leukocyte hydrolases on bacteria XI. Lysis by leukocyte extracts and by myelopoeroxidase of a Staphylococcus auerus mutant which is deficient teichoic acid and the inhibition of bacteriolysis by lipoteichoic acid. Proceeding of the Society for Experimental Biology and Medicine 1970; 159: 125–130
   Google Scholar
• Cantin A., Woods D. E. Protection by antibiotics against myeloperoxidase-depcndent cytotoxicity of lung epithelial cells in vitro. Journal of Clinical Investigation 1993; 91: 38–45
   PubMed Web of Science ®Google Scholar
• Kowanko I. C., Bates E. J., Ferrante A. Mechanisms of human neutrophil-mediated cartilage damage in vitro: role of lysosomal enzymes, hydrogen peroxide, and hypochlorous acid. Immunology and Cell Biology 1989; 67: 321–329
   PubMed Web of Science ®Google Scholar
• Katrantzis M., Baker M. S., Handley C. J., Lowther D. A. The oxidant hypochlotite (OCT-) a product of the myeloperoxidase system degrades artucular cartilage proteoglycan aggregate. Free Radicals in Biology and Medicine 1991; 10: 101–109
   PubMed Web of Science ®Google Scholar
• Yoshikawa S., Kayes S. G., Parker J. C. Eosinophils increase lung microvascular permeability via the peroxidase-hydrogen peroxide-halide system. Bronchoconstriction and vasoconstriction unaffected by eosinophil peroxidase inhibition. American Review of Respiratory Disease. 1993; 147: 914–920
   PubMed Web of Science ®Google Scholar
• Davies J. M., Horwitz D. A., Davies K. J.A. Potential role of hypochlorous acid and N-chloroamines in collagen breakdown by phagocytic cells in synovitis. Free Radicals in Biology and Medicine. 1993; 15: 637–643
   PubMed Web of Science ®Google Scholar
• Friedl H. P., Till G. O., Ryan U. S., Ward P. A. Mediator-induced activation of xantin oxidase in endothelial cells. FASEB Journal. 1989; 3: 2512–2518
   PubMed Web of Science ®Google Scholar
• Kusner D. J., King C. H. Protease modulation of neutrophil superoxide response. Journal of Immunology. 1989; 143: 1696–1702
   PubMedGoogle Scholar
• Taubman S. B., Cigen R. B. Cell-detaching activity mediated by enzyme(s) obtained from human leukocyte granules. Laboratory Investigations 1975; 32: 555–560
   PubMedGoogle Scholar
• Harlan J. M., Killen P. D., Harker L. A., Striker G. E., Wright D. Neutrophil-mediated endothelial injury in vitro, mechanisms of detachment. Journal of Clinical Investigation 1981; 687: 1394–1403
   Google Scholar
• Harlan J. M., Schwartz B. R., Reidy M. A., Schwartz S. M., Ochs H. D., Harker L. A. Activated neutrophils disrupt endothelial monolayer integrity by an oxygen radical independent mechanism. Laboratory Investigations 1985; 52: 141–150
   PubMed Web of Science ®Google Scholar
• Ginsburg I., Gibbs D. F., Varani J. Interaction of mammalian cells with polymorphonuclear leukocytes, reactive sensitivity to monolayer disruption and killing. Inflammation 1989; 13: 529–542
   PubMedGoogle Scholar
• Starke P. E., Farber J. L. Endogenous defenses against the cytotoxicity of hydrogen peroxide in cultured rat hepatocytes. Journal of Biological Chemistry 1985; 260: 86–92
   PubMed Web of Science ®Google Scholar
• Westlin W. F., Gimbrone M. A. Neutrophil-mediated damage to human vascular endothelium, role of cytokine activation. American Journal of Pathology 1993; 142: 117–128
   PubMedGoogle Scholar
• Giraldi T., Nisi C., Sava G. Lysosomal enzyme inhibitors and anti-metastic activity in the mouse. European Journal of Cancer 1977; 13: 1321–1323
   PubMed Web of Science ®Google Scholar
• Varani J., Ginsburg I., Schuger L., Gibbs D. F., Bromberg J., Johnson K. J., Ryan U. S., Ward P. A. Endothelial cell killing by neutrophils. Synergistic interaction of oxygen products and proteases. American Journal of Pathology. 1989; 135: 435–438
   PubMed Web of Science ®Google Scholar
• Gibbs D. F., Varani J., Johnson K. J. The cooperative interaction of oxidants and proteinases in endothelial cell injury by rat neutrophils. Federation of American Societies for Experimental Biology. 1993, Abstract No. 4130
   Google Scholar
• Janoff A. Elastase in tissue injury. Annual Reviews of Medicine 1985; 36: 207–216
   PubMed Web of Science ®Google Scholar
• Baird B. R., Cheronis J. C., Sandhaus R. A., Berger E. M., White C. W., Repine J. E. Oxygen metabolites and neutrophil elastase synergistically cause edematous injury in isolated rat lungs. Journal of Applied Physiology. 1986; 61: 2224–2229
   PubMed Web of Science ®Google Scholar
• Bartholomew J. S., Lowther D. A. Receptor-mediated binding of leukocyte elastase by chondrocytes. Arthritis and Rheumatism. 1987; 30: 431–438
   PubMedGoogle Scholar
• McGowan S. E., Murry J. J. Direct effect of neutrophil oxidants on elastase-induced extracellular matrix proteolysis. American Review of Respiratory Disease 1987; 135: 1286–1293
   PubMed Web of Science ®Google Scholar
• Rodcll T. C., Cheronis J. C., Repine J. E. Endothelial cell xantine oxidase-derived toxic oxygen metabolites contribute to acute lung injury from neutrophil elastase. Chest 1988; 93: 146s
   Google Scholar
• McDonald R. J., Bruekka L. U., Repine J. E. Neutrophil elastase augments acute edematous injury in isolated rat lungs perfused with neutrophil cytoplasts. American Review of Respiratory Disease. 1989; 140: 1825–1827
   PubMedGoogle Scholar
• Klebanoff S. J., Kinsella M. G., Wight T. N. Degradation of endothelial matrix heparan sulfate proteoglycan by elastase and the myeloperoxidase-H2O2-chloride system. American Journal of Pathology. 1993; 193: 907–917
   Google Scholar
• Palmgren M. S., deShazo R. D., Carter R. M., Zimmy M. L., Shah S. V. Mechanisms of neutrophil damage to human alveolar extracellular matrix, the role of serine metalloproteases. Allergy and Clinical Immunology 1992; 89: 905–915
   PubMedGoogle Scholar
• Pontremoli S., Melloni E., Michetti M., Sacco O., Sparatore B., Salamino F., Damiani G. Cytolystic effects of neutrophils, role for a membrane-bound neutrophil proteinase. Proceeding of the National Academy of Sciences of the United Stales of America 1986; 83: 1685–1689
   PubMedGoogle Scholar
• Adams D. G., Johnson W. J., Fiorito E., Nathan C. F. Hydrogen peroxide and cytolitic factor can interact synergistically in effecting cytolysis of neophastic targets. Journal of Immunology. 1981; 127: 1973–1977
   PubMedGoogle Scholar
• Hurkhardt H., Schwingel M., Menninger H., McCartney H. W., Tschsche H. Oxygen radicals as effectors of cartilage destruction. Direct degradative effects of matrix components and direct action via activation of latent collagenase from polymorphonuclear leukocytes. Arthritis and Rheumatism 1986; 29: 379–387
   PubMedGoogle Scholar
• Anthony V. B., Owen C., English D. D. Polymorphonuclear leukocyte cytoplasts mediate acute lung injury. Journal of Applied Physiology. 1988; 65: 706–713
   PubMedGoogle Scholar
• Abe H., Okajima K., Okabe H., Takatsuki K., Binder B. B. Granulocyte proteases and hydrogen peroxide synergistically inactivate thrombomodulin of endothelial cells in vitro. Journal of Laboratory Clinical Medicine 1994; 123: 874–881
   PubMed Web of Science ®Google Scholar
• Peppin G. J., Weiss S. J. Activation of endogenous metalloprotease, gelatinase by triggered human neutrophils. Proceeding of the National Academy of Sciences of the United States of America. 1986; 83: 4322–4326
   PubMed Web of Science ®Google Scholar
• Weiss S. J., Peppin G., Oritz X., Ragsdale C., Test S. T. Oxidative autoactivation of latent collagenase by human neutrophils. Science 1986; 227: 747–749
   Google Scholar
• Michaelis M., Visser M. C., Winterboum C. C. Different effects of hypochlorous acid on human neutrophil metalloproleases: Activation of collagenase and inactivation of collagenase and gelatinase. Archives of Biochemistry and biophysics 1992; 292: 555–562
   PubMedGoogle Scholar
• Capodici C., Muthukumaran G., Amoruso M. A., Berg R. A. Activation of neutrophil collagenase by cathepsin G. Inflammation 1992; 13: 245–258
   Google Scholar
• Shah S. V., Baricos W. H., Basci A. Degradation of human glomerular basement membrane by stimulated neutrophils, activation of metalloproteinase(s) by reactive oxygen metabolites. Journal of Clinical Investigation 1987; 79: 25–31
   PubMedGoogle Scholar
• Weiss S. J., Peppin G. Collagenolytic metalloenzymes of the human neutrophil, characteristics, regulation and potential function in vivo. Biochemical Pharmacology 1986; 35: 189–197
   Google Scholar
• Wert Z. C., Mainardi L., Vater C. A., Harris E. D. Endogenous activation of latent collagenase by rheumatoid synovial cells-evidence for the role of plasminogen activator. New England Journal of Medicine 1977; 269: 1017–1023
   Google Scholar
• Dennis E. A., Rhee S. G., Billah M. M., Hannun Y. A. Role of phospholipases in generating second messengers in signal transduction. FASEB Journal. 1991; 5: 2068–2077
   PubMed Web of Science ®Google Scholar
• Vadas P., Pruzanski W. Role of secretory phospholipase A2 in the pathobiology of disease. Laboratory Investigation 1986; 55: 391–404
   PubMed Web of Science ®Google Scholar
• Prizanski W., Vadas P. Soluble phospholipase A2 in human pathology, clinical laboratory interface. Biochemistry, molecular biology and physiology of phospholipase A₂, and its regulatory factors, A. B. Mukhergee. Plenum Press, New York 1990; 239–251
   Google Scholar
• Prizanski W., Vadas P. Phospholipase Ai-mediator between proximal and distal effectors in inflammation. Immunology Today 1991; 12: 143–146
   PubMedGoogle Scholar
• Bomalski J. S., Lawton P., Browing J. L. Human extracellular recombinant phospholipase A2 induces an inflammatory response in rabbit joints. Journal of Immunology. 1991; 146: 3904–3910
   PubMedGoogle Scholar
• Mormann B. J., Huang C. K., Mackin W. M., Becker E. L. Receptor-mediated activation of phospholipase A2 in rabbit neutrophil plasma membrane. Proceedings of the National Academy of Sciences of the United States of America 1984; 81: 767–770
   PubMedGoogle Scholar
• Kennedy S. P., Becker E. L. Ectophospholipase A2 activity of the rabbit peritoneal neutrophil. International Archive of Allergy and Applied Immunology 1987; 83: 238–246
   PubMedGoogle Scholar
• Victor M., Weiss J., Klempner M. S., Elsbach P. Phospholipase A2 activity in the plasma membrane of human polymorphonuclear leukocytes. Federation of European Biochemical Societies 1981; 136: 298–300
   PubMed Web of Science ®Google Scholar
• Henderson L. M., Chappell J. B., Jones O. T.G. Superoxide generation is inhibited by phospholipase A2 inhibitors. Role of phospholipase A2 in the activation of NADPH oxidase. Biochemical Journal 1989; 264: 249–255
   PubMedGoogle Scholar
• Watson F., Robinson J. J., Edwards S. W. Sequential phospholipase activation in the stimulation of the neutrophil NADPH oxidase. FEMS Microbiology Immunology 1992; 105: 239–248
   Google Scholar
• Forehand J. R., Johnston R. B., Bomalski J. S. Phospholipase A2 activity in human neutrophils. Stimulation by lipopolysaccharide and possible involvement in priming for an enhanced respiratory burst. Journal of Immunology 1993; 151: 4918–4925
   PubMedGoogle Scholar
• Engelberger W., Bitter-Suermann D., Hadding U. Influence of lysophospholipids and PAF on the oxidative burst. International Journal of Immunopharmacology 1987; 9: 275–282
   PubMedGoogle Scholar
• Ginsburg I., Ward P. A., Varani J. Lysophosphatidies enhance superoxide responses in stimulated human neutrophils. Inflammation 1989; 13: 163–174, (1989)
   PubMed Web of Science ®Google Scholar
• Kilgore K. S., Lucchesi B. R. Reperfusion injury after myocardial infarction: The role of free radicals and the inflammatory response. Clinical Biochemistry 1993; 26: 359–370
   PubMed Web of Science ®Google Scholar
• Patophysiology of severe ischemic myocardial injury, H. M. Piper. Kluwer Academic Publisher, Dodrecht/Boston/London 1990
   Google Scholar
• Ginsburg I., Kohen R., Ligumsky M. Ethanol synergizes with hydrogen peroxide, peroxyl radical and trypsin to kill epithelial cells in culture. Free Radicals in Biology and Medicine. 1994; 16: 263–269
   PubMedGoogle Scholar
• Klebanoff S. J. Oxygen metabolism and the toxic properties of phagocytes. Annals of Internal Medicine 1980; 93: 480–489
   PubMed Web of Science ®Google Scholar
• Dean R., Virelizier J. L. Interferon as macrophage activating factors. I. Enhancement of cytotoxic activity in the absence of other soluble signals. Clinical and Experimental. Immunology 1983; 51: 5011–511
   Google Scholar
• Shalaby M. R., Aggrawal B. B., Rinderknecht R., Svedersky L. P., Finkie B. S., Palladino M. A., Jr. Activation of human polymorphonuclear neutrophil functions by interferon-γ and tumor necrosis factor. Journal of Immunology 1985; 135: 2069–2073
   PubMed Web of Science ®Google Scholar
• Freund M., Pick E. The mechanism of action of lymphokines. VIII. Lymphokine-enhanced spontaneous hydrogen peroxide production by macrophages. Immunology 1985; 54: 35–45
   PubMedGoogle Scholar
• Wing E. J., Ampel N. M., Waheed A., Shadduck R. K. Macrophage colony stimulating factor (M-CSF) enhances the capacity of murine macrophages to secrete oxygen products. Journal of Immunology 1985; 135: 2052–2056
   PubMedGoogle Scholar
• Tsujimoto M., Yokota S., Viclek J., Weissman G. Tumor necrosis factor provokes superoxide anion generation from neutrophils. Biochemical and Biophysical Research Communications 1986; 137: 1094–1099
   PubMed Web of Science ®Google Scholar
• Klebanoff S. J., Vadas M. A., Harlan J. N., Sparks L. H., Gamble G. R., Agosti J. M., Watersdorph A. M. Stimulation of neutrophils by tumor necrosis factor. Journal of Immunology 1986; 136: 4220–4225
   PubMed Web of Science ®Google Scholar
• Figari I. S., Mori N. A., Palladino M. A., Jr. Regulation of neutrophil migration and superoxide production by recombinant tumor necrosis factor a and p: Comparison to recombinant interferon-γ and interleukin-la. Blood. 1987; 70: 979–984
   PubMed Web of Science ®Google Scholar
• Ferrante A., Nandoskar M., Walz A., Goh D. H.B., Kowanko I. C. Effects of tumor factor alpha and interleukin-1 alpha and beta on neutrophil migration, respiratory burst and dcgranulation. International Archives of Allergy and Applied Immunology 1988; 86: 8291
   Google Scholar
• Varani J., Bcndelew M. J., Sealy D. E., Kunkel S. L., Gannon D. E., Ryan U. S., Ward P. A. Tumor necrosis factor enhances susceptibility of vascular endothelial cells to neutrophil-mediated killing. Laboratory Investigations. 1988; 59: 292–295
   PubMed Web of Science ®Google Scholar
• Warren J. S., Kunkel S. L., Cunningham T. W., Johnson K. L., Ward P. A. Macrophage derived cytokines amplify immune complex-triggered O: responses by rat alveolar macrophages. American Journal Pathology. 1988; 130: 489–495
   PubMed Web of Science ®Google Scholar
• Ferrante A. Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: increased fungicidal activity against Tondopsis glaharaia/Candidtt albicans and associated increases in oxygen radical production and lysosomal enzyme release. Infection Immunity 1989; 57: 2115–2122
   PubMed Web of Science ®Google Scholar
• Kaplan S. S., Basford R. E., Wing E. J., Shadduck R. K. The effect of recombinant human granulocyte macrophage cology-stimulating factor on neutrophil activation in patients with refractory carcinoma. Blood. 1989; 73: 636–638
   PubMed Web of Science ®Google Scholar
• Kharazmi A., Nielsen H., Rechitzer C., Bendzen K. Interleukin 6 primes human neutrophils and monocyte oxidative burst response. Immunology Letters. 1989; 21: 177–184
   PubMed Web of Science ®Google Scholar
• Klein J. B., Scherzer J. A., McLeish K. R. Interferon-gamma enhances superoxide production in HL-60 cells stimulated with multiple agonists. Journal of Interferon Research. 1991; 11: 69–74
   PubMedGoogle Scholar
• Kownalzki E., Neumann M., Unrich S. Stimulation of human neutrophils granulocytes by monocyte-derived cytokines. Agents and actions. 1989; 26: 180–182
   PubMedGoogle Scholar
• Mege J. L., Cambronero J. G., Molski T. F.P., Becker E. L., Shaafi R. I. Effect of granulocyte-macrophage colony-stimulating factor on superoxide production in cytoplasts and intact human neutrophils, role of protein kinase and G-proteins. Journal of Leukocyte Biology 1989; 46: 161–168
   PubMedGoogle Scholar
• Nathan C. F. Respiratory burst in adherent human neutrophils, triggering by colony-stimulating factor GSF-GM and GSF-G. Blood 1989; 73: 301–306
   PubMed Web of Science ®Google Scholar
• Sullivan R., Predetle J. P., Socinski M., Elias A., Amman K. Enhancement of superoxide anion release by granulocytes harvested from patients receiving granulocyte-macrophage colony-stimulating factor. British Journal of Hematology. 1989; 71: 475–479
   PubMed Web of Science ®Google Scholar
• Borish L., Rosenbaum R., Albury L., Clark S. Activation of neutrophils by recombinant interleukin 6. Cellular Immunology 1989; 121: 281–289
   Google Scholar
• Melingaard A., Vercelloti G. M., Walker G., Nelson R. D., Jacob H. S. Tumor necrosis factor cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium. Journal of Experimental Medicine. 1990; 171: 2025–2041
   PubMedGoogle Scholar
• Kumaratilake L. M., Ferrante A., Bates E. J., Kowenko I. C. Augmentation of the human monocyte/macrophage chemiluminescence response during short-term exposure to interferon-gamma and tumor necrosis factor. Clinical and Experimental Immunology. 1990; 80: 257–262
   PubMedGoogle Scholar
• West M. A. Role of cytokines in leukocyte activation, phagocytic cells. Current Topics in Membranes and Transport 1990; 35: 537–570
   Google Scholar
• Badwey J. A., Bing J., Heyworth P. G., Robinson J. M. Products of inflammatory cells synergistically enhance superoxide production by phagocytic cells. Cell-cell interaction in the release of inflammatory mediators, P. Y.K. Wong, C. N. Serhan. Plenum Press, New York 1991; 19–33
   Google Scholar
• Balazowich K. J., Almeida H. I., Boxer L. A. Recombinant human GM-CSF and GM-CSF prime human neutrophils for superoxide production through different signal transduction mechanisms. Journal of Laboratory and Clinical Medicine 1991; 118: 576–584
   PubMedGoogle Scholar
• Kapp A., Komann A., Schopf E. Effect of tumor necrosis factor alpha in vivo on human granulocyte oxidative metabolism. Archives for Dermatological Research 1991; 283: 362–365
   PubMedGoogle Scholar
• Klein J. B., Scherzer J. A., McLeish K. R. Interferon-γ enhances superoxide production by HL-60 cells stimulated by multiple agonists. Journal of Interferon Research 1991; 11: 69–74
   PubMedGoogle Scholar
• Tannenberg S. D. The effect of inflammatory mediators on neutrophil functions. New aspects of human polymorphonuclear leukocytes, W. H. Horol, P. J. Schollmeyer. Plenum Press, New York 1991; 75–92
   Google Scholar
• Ferrante A. Activation of neutrophils by interleukins-1 and 2 and tumor necrosis factors. Granulocyte responses to cytokines, basic and clinical research, R. G. Coffey. Marcel Dekker, New York 1992; 417–436
   Google Scholar
• Yuo A., Kitagawa S., Motoyoshi K., Azuma E., Saito M., Takaku F. Rapid priming of human monocytes by human hematopoietic growth factor: granulocyte-macrophage colony-stimulating factor (CSF), macrophage-CSF, and interleukin-3 selectively enhance superoxide release triggered by receptor-mediated agonists. Blood 1992; 79: 1553–1557
   PubMed Web of Science ®Google Scholar
• Khwaja A., Carver J. E., Linch D. C. Interaction of granulocyte-macrophage colon) -stimulating factor (CSF). granulocyte CSF. and tumor necrosis factor in priming of the neutrophil respiratory burst. Blood. 1992; 79: 745–753
   PubMed Web of Science ®Google Scholar
• Williams J. G., Jutkovich G. J., Hahnel G. B., Mailer R. W. Macrophage priming by interferon gamma: a selective process with potential harmful effects. Journal Leukocyte Biology 1992; 52: 579–584
   PubMedGoogle Scholar
• Baglioni C. Mechanisms of cytotoxicity, cytolysis and growth stimulation by TNF. Tumor necrosis factor: the molecules and their emerging role in medicine, B. Beutler. Raven Press, New York 1992; 425–438
   Google Scholar
• Gomez-Cambronero J., Sha'afi R. I. Granulocyte-macrophage colony-stimulating factor and neutrophil, mechanisms of action. Cell-tell interaction in the release of inflammatory mediators, P. Y.K. Wong, C. N. Serhan. Plenum Press, New York 1992; 35–71
   Google Scholar
• Tannenberg S. D., Fey D. E., Lieser M. J. Oxidative priming of neutrophils by inlerferon-Y. Journal of Leukocyte Biology 1993; 53: 301–308
   PubMedGoogle Scholar
• Ogle J. D., Noel J. G., Sramkoski R. M., Ogle C. K., Alexander J. W. Effects of combination of tumor necrosis factor alpha and chemotactic peptide f-MET-LEU-PHE on phagocytosis of opsonized microspheres by human neutrophils. Inflammation 1992; 16: 57–68
   PubMedGoogle Scholar
• Hatsura Y., Tsuru S., Noritake M., Kayashima H., Shimomiya N., Shinomiya M., Rokutanda M. Granulocyte colony-stimulating factor enhances the extracellular emission of reactive oxygen from neutrophils stimulated with formylmethionyl eucylphenylalanine. Cellular Immunology. 1993; 148: 10–17
   PubMedGoogle Scholar
• Wozniak A., Betts W. H., Murohy G. A., Rocicinski M. Interleukin-8 prime human neutrophils for enhanced superoxide anion production. Immunology. 1993; 79: 608–615
   PubMed Web of Science ®Google Scholar
• Edward S. W., Say J. E., Hughes V. Gamma interferon enhances the killing of Staphylococcus aureus by human neutrophils. Journal of General Microbiology 1988; 134: 37–42
   PubMedGoogle Scholar
• Kowanko I. C., Ferrante A., Harvey D. P., Carman K. L. Granulocyte-macrophage colony-stimulating factor augments neutrophil killing of Torulopsis glahrala and stimulates neutrophil respiratory burst and degranulation. Clinical and Experimental Immunology. 1991; 83: 225–230
   PubMedGoogle Scholar
• Roilides E., Uhlig K., Venzon D., Pizzo P. A., Walsh T. J. Enhancement of oxidative response and damage caused by human neutrophils to Asppergitlus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infection Immunity 1993; 61: 1185–1193
   PubMed Web of Science ®Google Scholar
• Kushner B. H., Cheung N. K.V. GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma. Blood 1989; 73: 1936–1941
   PubMed Web of Science ®Google Scholar
• Baud L., Affres H., Perez J., Ardiallou R. Reduction in tumor necrosis factor and cytotoxicity by hydrogen peroxide. Journal of Immunology 1990; 166: 556–560
   Google Scholar
• Abramson S. L., Gallin J. I. 11-4 inhibits superoxide production by human mononuclear phagocytes. Journal of Immunology 1991; 244: 625–630
   Google Scholar
• Simon R. H., DeHart P. D., Nadeau D. M. Resistance of rat pulmonary alveolar endothelial cells to neutrophil-and oxidant-induced injury. American Journal of Respiratory Cellular and Molecular Biology 1989; 1: 221–229
   PubMed Web of Science ®Google Scholar
• Dallegri F., Ballestrero A., Ottonello L., Patrone F. Platelets as inhibitory cells in neutrophil-medialed cytolysis. Journal of Laboratory and Clinical Medicine. 1989; 114: 502–509
   PubMedGoogle Scholar
• Berger E. M., Beehler C. J., Harada R. N., Repine J. E. Human phagocytic cells as oxygen metabolite scavengers. Inflammation. 1990; 14: 613–619
   PubMedGoogle Scholar
• Scott M. D., Lubin B. H., Zuo L. X., Kuypres F. A. Erythrocyte defense against hydrogen peroxide: Preeminent importance of catalase. Journal of Laboratory and Clinical Medicine. 1991; 188: 7–16
   Google Scholar
• Chevion M. A site-specific mechanism for free radical induced biological damage: the essential role of redox-active transition metals. Free Radical Biology and Medicine. 1988; 5: 27–37
   PubMed Web of Science ®Google Scholar
• Scott J. A., Fischman A. J., Homey C. J., Fallon J. T., Khaw B. A., Peto C. A., Rabito C. A. Morphologic and functional correlates of plasma membrane injury during oxidant exposure. Free Radicals in Biology and Medicine. 1990; 6: 361–367
   Google Scholar
• Nathan C., Silverstein S. S., Brukner L. H., Cohn Z. A. Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity. Journal of Experimental Medicine 1979; 149: 100–113
   PubMed Web of Science ®Google Scholar
• Martin J. Neutrophils kill pulmonary endothelial cells of a hydrogen peroxide-dependent pathway. American Review of Respiratory Disease 1984; 130: 209–213
   PubMed Web of Science ®Google Scholar
• Becker E. L. The cytotoxic action of neutrophils on mammalian cells in vitro. Progress in Allergy. 1988; 40: 183–208
   PubMedGoogle Scholar
• Varani J., Fligiel S. E.G., Till G. O., Kunkel R. G., Ryan W. S., Ward P. A. Pulmonary endothelial cell killing by human neutrophils. Possible involvement of hydroxyl radical. Laboratory Investigations 1985; 53: 656–663
   PubMed Web of Science ®Google Scholar
• Gannon D. E., Varani J., Phan S. H., Ward J. H., Kaplan J., Till G. O., Simon R. H., Ward P. A. Source of iron in neutrophil-mediated killing of endothelial cells. Laboratory Investigations. 1987; 57: 34–44
   Google Scholar
• Puppo A., Halliwell B. Formation of hydroxy! radicals from hydrogen peroxide in the presence of iron. Biochemical Journal. 1988; 249: 185–190
   PubMed Web of Science ®Google Scholar
• Gerschenson L. E., Rottelo R. J. Apoptosis, a different type of cell death. FASEB Journal. 1992; 6: 2450–2455
   PubMed Web of Science ®Google Scholar
• Butlke T. M., Sandstrom P. A. Oxidative stress as a mediator of apoptosis. Immunology Todav 1994; 15: 7–10
   PubMedGoogle Scholar
• Catheart M. K., McNally A. K., Morel D. W., Chislom G. M. Superoxide anion participation in human monocyte-mediated oxidation of low density lipoprotein in conversion of low-density lipoproteins to cytotoxins. Journal of Immunology. 1989; 142: 1963–1969
   PubMedGoogle Scholar
• McCord J. M., Fridovich I. Superoxide dismutase, the first twenty years (1969 1988). Fire Radicals in Biology and Medicine. 1988; 5: 363–369
   PubMed Web of Science ®Google Scholar
• Flore L. Superoxide dismutase for therapeutic use: clinical experience, dead ends and hopes. Molecular and Cellular Biochemistry. 1988; 84: 123–131
   PubMedGoogle Scholar
• Greenwald R. A. Superoxide dismutase and catalasc as therapeutic agents for human disease. A critical review. Free Radicals in Biology and Medicine. 1990; 8: 201–209
   PubMed Web of Science ®Google Scholar
• Gross A. R. Inhibitors of leukocyte superoxide generating oxidase: mechanisms of action and methods for their evaluation. Free Radicals in Biology and Medicine. 1990; 8: 71–93
   PubMedGoogle Scholar
• Halliwell B., Gutteridge J. M.C., Cross C. E. Free radicals, antioxidants, and human disease: Where are we now?. Journal of Laboratory and Clinical Medicine 1992; 119: 598–620
   PubMed Web of Science ®Google Scholar
• Rice-Evans C. A., Diplock A. T. Current status of antioxidant therapy. Free Radical in Biology and Medicine. 1993; 15: 77–96
   PubMed Web of Science ®Google Scholar
• Rose R. C., Bode A. M. Biology of free radical scavengers: an evaluation of ascorbate. FASEB Journal 1993; 7: 1135–1142
   PubMed Web of Science ®Google Scholar
• Harris E. D. Regulation of antioxidant enzymes. FASEB Journal. 1992; 6: 2675–2683
   PubMed Web of Science ®Google Scholar
• Chwalwijk J., Van Der Berg W. B., Van Der Pute L., Joosten L. A.B., Van Bersselaar L. Cationization of catalase, peroxidase and superoxide dismutase. Effect of improved intraarticular retention on experimental arthritis in mice. Journal of Clinical Investigation. 1985; 76: 198–205
   PubMedGoogle Scholar
• Gibbs D. F., Varani J., Ginsburg I. Formation and use of poly-L-histidine catalasc complexes: protection from hydrogen peroxide-mediated injury. Inflammation. 1989; 13: 465–474
   PubMed Web of Science ®Google Scholar
• Kohen R., Kakundaand A., Rubinstein A. The role of cationized catalase and cat ionized glucose oxidase in mucosal oxidative damage induced in the rat Jejunum. Journal of Biological Chemistry. 1992; 267: 21349–21354
   PubMed Web of Science ®Google Scholar
• Rubinstein A., Kakunda A., Kohen R. Protection of the rat Jejunal mucosa against oxidative injury by cationized superoxide dismutase. Journal of Pharmaceutical Sciences. 1993; 82: 1285–1287
   PubMedGoogle Scholar
• Nussier A. K., Billar T. R. Inflammation, immunoregulation, and inducible nitric oxide sythase. Journal of Leukocyte Biology. 1993; 54: 171–178
   PubMedGoogle Scholar
• Feldman P. L., Griffith O. W., Stuehr D. J. The surprising life of nitric oxide. Chemical and Engineering News. 1993; 20: 26–38
   Google Scholar
• Cazevieille C., Muller A., Meynier F., Bonne C. Superoxide and nitric oxide cooperation in hypoxia/reoxygenation-induced neuron injury. Free Radicals in Biology and Medicine. 1993; 14: 389–395
   PubMed Web of Science ®Google Scholar
• Beckman J. S., Beckman T. W., Chen J., Marshall P. A., Freeman B. A. Apparent hydroxyl radical production by peroxinitrite: implications for endothelial injury from nitric oxide and superoxide. Proceeding of the National Academy of Sciences of the United States of America. 1990; 87: 1620–1624
   PubMed Web of Science ®Google Scholar
• Rubanyi G. M., Ho E. H., Cantor E. H., Lumma W. C., Parker B. L.M. Cytoproteclive function of nitric oxide: inactivation of superoxide radical induced by human leukocytes. Biochemical and Biophysical Research Communications. 1991; 181: 1392–1397
   PubMed Web of Science ®Google Scholar
• Ginsburg I. Can hemolytic streptococci be considered “forefathers” of modern phagocytes? Both cell types freely migrate in tissues and kill targets by a “cross-talk” among their secreted agonists. Comparative Biochemistry and Physiology 1994, in press
   Google Scholar